The highly potent and selective anti-herpesvirus agent , (E)-S-(2-bromovinyl)-2 'deoxyuridine (BVdU), was examined fo r its inhibitory effect on the salmonid herpesviruses 01l (;orhynchus masou virus (OMV ) and Herpesvirus salmol/is (11. salmrmis) . Minimum inhibitory concentra tions (M IC) of BVdU for OMV and H. salmol/is were 1.25 and 3.0 pg/ml, respectively ; these valut:s were equal to or higher than those obtained for acyclovir or cytarabin. OMV DNA polymerase activity was reduced in a dose-dependent fashion by BVdU 5'-triphosphate (BVdUTP) within the concentration range of3 to 30 pM. However, BVdUTP could also be substituted for the natural substrate. TTP, in the OMV DNA polymcrase assay. It is postulated that the inhibitory action of BVd U on the salmonid herpesviruses is more or less similar to that on other herpesviruses and resides with respect to the inhi bition of the virus DNA polyme rase activity as well as incorporation of BVd U in to the viral DNA.
T he fi sh herpesvirus Oncorhynchus masou virus (O MV) is th e causative agent of infect ious hepatitis in salmonid fish ( II , IS) . This virus also has oncogenic potential ( 12) . The antiviral activi ty of acyclovir, 9-(2-hydroxyelhoxymethyl)guanine (Acyclovir; ACV) . agai nst OMV and related Herpesvirus salmonis (H. salmonis) (20,2 1) has been studied both ill vitro and ill vivo. ACV is inhibitory for both OMV and H. salmollis in vitro and also able to prevent OMV infection in vivo (13, 14) .
(E)-S-(2-Bromovinyl)-2'-deoxyuridine (BVdU) is one of the most efficient a ntiherpetic compounds described to date. It inhibits the replication of several mammalian herpesviruses such as h erpes simplex virus type I, varicel la-zoster virus, suid herpesvirus type I and bovid herpesvirus type I, at concentrations fa r below the cytotoxicity threshold. BVdU is specificall y phosphorylated by virus-induced thymidine kinase and targeted at vira l DNA synthesis (4-S, 10, 18).
We have exami ned the antiviral activity of BVdU against OMV a nd H. salmollis in vitro, based on m inimum inh ib itory concentration ( M IC ) and inhibition of viral re plication . Compounds included as reference were ACV, 9-p-o-arab inofuranosyladenine (AraA), and I-p -D-arabi nofuranosylcytosine (AraC). BVdU was also . ..
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investigated for its effect on infectious hematopoietic necrosis virus (I HNV), a nd the toxicity of BVd U on the host (RTG-2) cells was assessed . OMY DNA polymerase was isolated and purified , a nd nVdU-5'-triphosphat e (BVdUTP) was examined for it s capacity to ac t as inhibit or o r subst rate (or bo th ) of O MY DNA polymerase.
MATERIALS AND METHODS

AIIliuiral com/JDumis.
nVdU [(E)-5-(2-hromovinyl)-2'-deoxyuridine] was synthesized accordi ng to the method of J ones el al (10) and BVdUTP (BVdU 5'· triphosphate) was prepared as descri bed by Allaudeen et al ( I) . AraA (9-P-Da rabinofuranosyladcni ne) was provided by Ajinomoto Co., Ltd. (K awasaki, Japan).
Arne ( I-p -o-arabinofuranosylcytosine) was from Yamasa Co. , Ltd. (Choshi , J apan) and ACV [acyclovir, 9.(2-hydroxyethoxymethyl)g ua nine] was obtained through the V courtesy of the Well come Foundation Ltd. (London , England ). BVdU , AraA and ACV were dissolved in double-dist illed water to give a concentration of I Illg /ml , :I.nd AraA to give a conce ntratio n of 0.5 mg/Illl. After passage through a Millipore filt er (0.45 ~m ) , they were stored at 0 C until use. BVdUTP was dissolved at a co ncentratio n of I m M in EtO H using max. = 296 and, = 11 ,665 . I t was a lso sto red a t 0 C unt il use.
Viruses. O",orhY IU:hus masou virus (OMY, strain 00-78 12) and H erpesvirus salmonis (H . salmonis ) were used as representative of the pathogenic herpesviruscs of fi sh. Infectious hematopoie tic necrosis virus (IH NV, strain ChAb) was used as a reference. OMV was isolated from ovarian fluid s of masou salmon caught in 1978 in Hokkaido (Japan). H. salmO/lis was kindly provided by Dr. K. Wolf of the Nationa l Fish Health Research Laboratories (West Virgin ia, U.S.A.) and I HN V was isola ted from chum sa lmon (Oncorhynchus keta) in 1976 in Ho kkaido (Japan). The viruses were propagated in RTG-2 or K O-6 cel ls as described be low and stored at -80 C unti l usc.
Cells. Ra inbow trout (Salmo gairdnni) gonad cells ( RTG-2) ( 19) were used throughout a ll experiments except for those aimed a t isolating O MV DNA polymerase for which kokanee sa lmo n (0. nerka) ovary cells ( KO-6) ( 15) were used . The cells were maintained in Eagle's minimum es.~ntial medium (MEM , Gibeo ; Grand Island, N.Y., U.S.A .) , supplemented with 10 % feml bovi ne serum (Gibeo), 100 I U of penici llin and 100 flg /m l of streptomyc in (Sigma, St. Louis, Mo. , U.S.A. ), and incubated at 15 C.
Antiviral activity. Monolayers of RTG -2 cells, seeded in 24 well tissue culture plates (Falcon; Oxnard, Calif. , U.S.A. ), were infected with 100 TC I Dw/ml of virus and then BVd U. AC V, AraA or AraC we re added. The cells infec ted wi th OMY and IHNV were incubated at 15 C for 10 days. T he cells infected wi th H . salmollis were kept a t 10 C for 14 days. The n, the viral cytopa thic effec t (CPE) was determined o n crystal violet stai ning. Antiviral activity was expressed as m inimum inhibitory concentration (MIC) which was defined as the minimum concentration of the antivira l compou nd required to inhibit th e viral C PE completely. /:..JJect f!! BVdU on replicatioll of OM V. RTO-2 cells were seeded in 25 cm~ tissue culture Hasks (Falcon) at 8.0 X 10 5 cells/Hask. After 3 days of incubation a t 15 C, the R TO-2 monolayers were infected with 0.5 ml of OMV suspension containing 10 3 TCIDso/m!. After a 2 hr-adsorption period, BVdU was added at fi nal concentrations of 0, 0.5, 1.0, and 2.0 pg/ml , and the cell cultures were further incubated at 15 C. The virus titer in the cel l cu lture fl uid was assayed on RTG-2 cel ls by the 50 % tissue culture infect ious dose (TCI Dw/ml) at selected time int ervals (2, 4, 6, 8, 10, and 12 days after virus inoculation).
Effect of BVdU on RTG-2 cell growth . 10' RTG-2 cel ls were suspended in 5 ml of MEM in 25 em\! tissue c ulture flasks (Falcon). After incubat ion at 15 C for 3 days, BVdU (0, 0.5,1.0, or 2.0pg/ml) was added to the cells, which were then fu r ther incubated a t 150. Two, 7, and 12 days after the addition of BVdU, the ccl ls were dispersed with trypsin a nd suspended in 5 ml of H a nds' bala nced salt solution (BSS, G ibeo). The number of cells was determined wi th a hemocytometcr.
Purificatio1/ of OMV DNA polymerase. Purification of OMV DNA polymerase was carried out by a modificat ion of the method of Suzuki et al (18) . KO-6 cells seeded in t issue culture flasks were infected with OMV (at a mult ipl icity of infec tion > 10) and incubated fo r 24 hr a t 15 C. Cells were then suspended in an hypotonic buffer [50 mM Tris-H C I (p H 7.5), 200 mM KCl, I mM 2-mercaptocthanol, 20 % (v/v) Triton X-100] and homogenized by a sonicator (Tomy UR-50) until comple te destruction of thc cells. Homogenatcs were centrifuged a t 30,000 rpm for 120 min (Beckman SW50-1 rotor); the superna ta nt was dialyzed for 1-2 hr against buffer A [20 mM T ris-HCI (pH 7.5), I mM EDTA, 10 m M 2-mercaptoethanol and 20 % (v/v) glycerol] , a nd a pplied to a EDT A-cellulose (Whatman, DE-52) column equilibra ted wi th buffer A containing 20 mM K C I. OMV DNA polymerase was eluted from the column with a linear gradient of20 mM (I SO ml) to 500 mM (150 ml) K CI in buffer A at a flow rate of 20 ml /hr.
The active peak of O MV DNA polymerase was detected in the frac tions containing 220 mM KCI. Fractions 50 through 67 were pooled and dialyzed against buffe r A containing 20 mM K C ] a nd then appli ed to a phosphocellu lose (Whatman P_I I) column equi librated wi th buffer A containing 20 mM K C!. The DNA polymerase was eluted from the column with a linear gradient ranging from 50 mM (70 ml) to 650 mM (70 ml) K CI in buffer A a t a fl ow rate of 10 ml /hr. The active peak of OMV DNA polymerase was detected in the fra ct ion containing 420 mM KCI. Fractions 53 through 59 were pooled a nd dialyzed against a buffer containing 50 mM Tris-H CI (pH 7.5), 10 mM 2-mercaptoethanol, I mM EDT A, 150 mM KCI and 60 % glycerol, and stored at -20 C until use.
OMV DNA polymerase assay. T he standard reaction mixture for OMV DNA polymerase activity contained 50 mM Tris·HCI (p H 7.8), 4-mM MgCI 2 , 0.5 mM d ithiothreitol (DTT), 70 pM each of dATP, dGTP and dOTP, 7 pM TTP, [me thyl. 3H]TTP or GTP (1.7 pCi/nmol), 2.5 pg of activated DNA and 1.4 units of enzyme in a total volume of 25 p I. To distinguish OMV DNA polymerase from cel l DNA polymerase, 100 mM ammonium sulfa te was added to the reaction mixture containing O M V DNA polymerase (18) . O ne unit of enzymatic activity was defined as t he amount requ ired to incorporate 1 nmol dNTP into DNA for 1 hr. T he incu bation was carried out at 25 C fo r 20 min. The reaction m ixture was ch illed and 20 p i a liquot! were transferred to DEAE-cel lu lose (What man DE.80) paper disks. The disks were washed six limes with 5 % Na2 HP04 a nd twice w ith ethanol, and then dried. The disks were Ihen eva luated for radioactivity in a liquid scintil· lation cou nter.
I~ESUI : rs
Antiviral Effects oj BVdU. !leV, Arae, and Aroll
The antiviral effects of BVdU, ACY, Arae, and AraA were evaluated in RTG·2 cel ls infected with OMY, IH NV, or H. salmonis. The results were expressed by MI C, and arc shown in Table I . M IC values of BVdU, ACV, Arae, and AraA for QMY were 1.25, 1.25,2.0, and > 250 fJg /ml, respectively. For H. sa/monis, they were 3.0, 2.0, 2.0 , a n d > 250.ug/m l, respect ively. For IH NV they were all > 100 .ugfml. From these resu lts, it was apparent that BVdU had an antiviral activity equal to o r higher than ACV o r AraC against the fish herpesviruses, whereas AraA had no effect whatsoever eve n at concentrations up to 250 .ug/m l. None of the fou r compou nds had any e ffec t against the non-herpesvirus, I H NV, at a concentration up to loopg/ ml .
Effect of BVdU 011 OMV Replication
Growth curves of OMV in the presence of var ious concent rations of BVd U (0, 0.5, 1.0, and 2.0 I4g/m1) are shown in Fig. I . In the control Aask, the OMV ti ter in the cell culture flu id reached about 10 6 T C I Dw/ml on the 14th day after infection. In the ce ll cu lt ure treated with BVd U a t 0.5 .ugfm l, the O M Y ti ter reached about 104 .~ TCI Dw/m l, a nd when BYdU was added at 1.0 pg/ml , the maximum virus titer ac hieved was about 10~u TC I Dw/m l. On addition of 2.0 .ug/ml of BVdU , the maximum virus t iter attained was on ly 10 2 . 0 TCI DMI/ml. II Ih us appeared that at 0.5 ps/ml , BVdU caused 96.8 % inh ibition of OMV replication, at 1.014g/ml 99.6 % inhib ition, a nd 2.0 pg/ml 99.99 % in hibition. At the concent rat ions o fB VdU (0.5, 1.0, and 2.0.ug/m l) which were fo und effec tive in suppressing virus infection (T able 1 and Fig. 1 ), BYdU had no inh ibitol'Y effect on growth of the host cells (data not shown) . OMV DNA polymerase by 18.7,34.7, and 45.2 %, respectively (Fig. 2) . When added at 25 P.M, BVd UT P suppressed aMV DNA polymerase activit y by 71.2 %.
Uti/iulio,1 0/ BVdUTP as Substrate/or OMV DNA Polymerase
The amounts of DNA synthesized by aMV DNA polymerase, utilizing either BVdUTP or TTP as substrate, arc depicted in Fig. 3 . The amounts of DNA synthesized increased with increasing concentrations of TIP or BVdUTP in the reaction mixture. At the saturating concentration of 30 P.M, the amount of DNA synthesized with BVdUTP as substrate was abou t 75 % the a mount of DNA synthesized wi th "I~rp as substrate.
DI SCUSS ION
BVdU is onc of the most effieient antiherpcsvirus com pounds known to date. It is particularly act ive against HSV-I and VZV (4) (5) (6) . H owever, HSV-2 is about 200 ti mes less susceptible to BVdU than HSV-l. BVdU is an average of five to ten limes effective than ACV against HSV-I , but aga inst HSV-2 il is about 25 ti mes less effective than ACV (4) (5) (6) .
In this study, the a ntivira l effects of BVdU against the fish pathogenic herpe!lviruses aMV and H. salmanu were determined in vitro and compared with those of ACV. Arae, a nd AraA. The MI Cs of AraA for both OMV and H . sa/mom's were all > 250 pgl m l ; thus AraA had no act ivity against these viruses. MICs of BVdU, ACV, and Arae for QMV were 1.25, 1.25, and 2.0 pgl m l, and those fo r H . salmoni! was 3.0, 2.0, and 2.0 pg/ml, respectively. BVdU, ACV, a nd AraC wcre almost equally acti ve against QMV and H . salmonis. None of the four com pounds had any activity against the rhabdovirus, IHNV. At concentrat ions (0.5, 1.0, a nd 2.0 pg/ml) whic h did not im pair growth of the host cel ls, BVdU caused a concentrationdependent reduction in OMY yields (Fig. I ) , suggesting that its a nti-OMV act ivity was specific.
The MI CsofBVdU , Arae, andACV for OMVandH. salmonis were substantially higher than those reported previously for BVdU, AraC, and ACV against HSV-l (5). As far as BVdU is concerned, phosphorolysis by pyrimidine nucleotide phosphorylases (8) may contribute to premature degradation of the compound and, therefore, a n increased a ntivira l effect may be achieved by replenishing the cell culture medium with fresh BVdU a t regular time intervals.
The selectivity of BVd U as a n antiherpes compound is essentially based on two virus-induced enzymes, thymidine (Thd) kinase a nd D NA polymerase (7) . The HSV-I-induced dThd kinase converts BVdU successively to its 5'-mono-and 5'-diphosphate, which is then further converted by cellular kinase(s) to the 5'-tri phosphate (BVdUTP). BVdUTP selectively inhibits the act ivities of HSV-I and VZV DNA polymerase ( I , 22) and it can also serve as a substra te fo r the synthesis of viral DNA (2, 16) . T his mec hanism of action is simila r to that proposed for ACV (3, 9, 17) .
The interaction of BVd U with OMV DNA polymerase was also investigated in the present study. OMV DNA polymerase activity was reduced by 71.2 % if 25 p~1 BVdUTP was added to the reaction mixture (Fig. 2) . Therefore an investigation was performed to determine if BVdUTP was incorpora ted into DNA as a substrate by OMV DNA polymerase. When IfP was substituted by BVd UT P, DNA synthesis was reduced only by about 25 % (Fig. 3) . It was suggested that under these conditions BVdUTP was incorpora ted into the DNA instead of TIP, but the incorporative ratio of BVdUTP was only 25 % of that of TTP. Thus BVdUT P not only inhibi ts DNA polymerase activity but also acts as a substrate fo r OMV DNA synthesis. In this sense its interac tion with OMV DNA synthesis is considered to be similar to that previously establ ished for other herpesvirus such as H SV-I and VZV.
The an tiviral effect of BVdU on fish herpesviruses in vioo is a subject of future studies.
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